Cingulate
Price & Volume
Stats
See more52W Range | $1.80-$20.83 |
Market Cap | $20.4M |
Shares Short | 194,876 |
Financials
See moreRevenue (12 Mos) | $0 |
Revenue Growth (YoY) | 0% |
Gross Profit (12 Mos) | -$9.8M |
Diluted EPS | -$4.03 |
News
See moreYahoo Finance • 11 days ago
Cingulate names Nilay Patel as chief legal officer ahead of FDA filing
Yahoo Finance • 4 months ago
Cingulate Inc. Reports Full Year 2024, Fourth Quarter Results, and Provides Development Update on Major Milestones Achieved
Yahoo Finance • 2 years ago
Cingulate Inc. Reports Third Quarter 2023 Financial Results and Provides Clinical and Business Update
Yahoo Finance • 2 years ago
Cingulate to Host CNS Key Opinion Leader Panel in New York City
About
CEO | Dr. Shane J. Schaffer Pharm.D. |
CFO | Ms. Jennifer L. Callahan CPA |
Address | 1901 West 47th Place, Kansas City, KS, United States, 66205 |
Sector | Healthcare |
Industry | Biotechnology |
Full-Time Employees | 13 |
